Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

US Blocks Asymchem’s $58 Million Acquisition of Boston’s Snapdragon

publication date: Sep 13, 2022

Asymchem’s $58 million acquisition of Boston’s Snapdragon Chemistry, a cross-border tie-up of CDMOs, was blocked by US regulators. Asymchem, headquartered in Tianjin, but with operations also in the US and EU, is a CDMO. Snapdragon, a Boston-area company with expertise in flow chemistry, has developed a novel advanced continuous manufacturing program and built a manufacturing facility with up to 30kg capacity. The US Treasury’s Committee on Foreign Investment in the United States (CFIUS) refused to approve the acquisition, in part because Snapdragon developed its technology with US government funds, and CFIUS did not want a China-based company to own the technology. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital